Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995
Description:
Networks of Innovation offers a historical perspective on the manner in which private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp & Dohme, which acquired Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. By surveying a century of innovation in biologicals, the authors show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad.
Best prices to buy, sell, or rent ISBN 9780521626200
Frequently Asked Questions about Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995
The price for the book starts from $7.98 on Amazon and is available from 20 sellers at the moment.
If you’re interested in selling back the Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995 book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995 book, the best buyback offer comes from and is $ for the book in good condition.
The Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995 book is in very low demand now as the rank for the book is 6,057,844 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.